Tamoxifen "Ebewe" comprimate 10 mg Republica Moldova - română - AMDM (Agenţia Medicamentului şi Dispozitivelor Medicale)

tamoxifen "ebewe" comprimate 10 mg

ebewe pharma gmbh nfg. kg - comprimate - 10 mg

Tamoxifen "Ebewe" comprimate 20 mg Republica Moldova - română - AMDM (Agenţia Medicamentului şi Dispozitivelor Medicale)

tamoxifen "ebewe" comprimate 20 mg

ebewe pharma gmbh nfg. kg - comprimate - 20 mg

TAMOXIFEN SOPHARMA 10 mg România - română - ANMDM (Agentia Nationala a Medicamentului si a Dispozitivelor Medicale)

tamoxifen sopharma 10 mg

cn unifarm s.a. - tamoxifenum - compr. - 10mg - antagonisti hormonali si substante inrudite antiestrogeni

Tamoximed comprimate 10 mg Republica Moldova - română - AMDM (Agenţia Medicamentului şi Dispozitivelor Medicale)

tamoximed comprimate 10 mg

balkan pharmaceuticals srl, sc - tamoxifenum - comprimate - 10 mg

Tamoximed comprimate 20 mg Republica Moldova - română - AMDM (Agenţia Medicamentului şi Dispozitivelor Medicale)

tamoximed comprimate 20 mg

balkan pharmaceuticals srl, sc - tamoxifenum - comprimate - 20 mg

Femara comprimate filmate 2,5 mg Republica Moldova - română - AMDM (Agenţia Medicamentului şi Dispozitivelor Medicale)

femara comprimate filmate 2,5 mg

novartis pharma ag - letrozolum - comprimate filmate - 2,5 mg

Exedrol comprimate 25 mg Republica Moldova - română - AMDM (Agenţia Medicamentului şi Dispozitivelor Medicale)

exedrol comprimate 25 mg

balkan pharmaceuticals srl, sc - exemestanum - comprimate - 25 mg

Verzenios Uniunea Europeană - română - EMA (European Medicines Agency)

verzenios

eli lilly nederland b.v. - abemaciclib - sânii neoplasme - agenți antineoplazici - early breast cancerverzenios in combination with endocrine therapy is indicated for the adjuvant treatment of adult patients with hormone receptor (hr) positive, human epidermal growth factor receptor 2 (her2) negative, node positive early breast cancer at high risk of recurrence (see section 5. in pre or perimenopausal women, aromatase inhibitor endocrine therapy should be combined with a luteinising hormone-releasing hormone (lhrh) agonist. advanced or metastatic breast cancerverzenios is indicated for the treatment of women with hormone receptor (hr) positive, human epidermal growth factor receptor 2 (her2) negative locally advanced or metastatic breast cancer in combination with an aromatase inhibitor or fulvestrant as initial endocrine-based therapy, or in women who have received prior endocrine therapy. in pre- or perimenopausal women, the endocrine therapy should be combined with a lhrh agonist.

Zitazonium comprimate 10 mg Republica Moldova - română - AMDM (Agenţia Medicamentului şi Dispozitivelor Medicale)

zitazonium comprimate 10 mg

egis pharmaceuticals plc - tamoxifenum - comprimate - 10 mg

LEZRA 2,5 mg România - română - ANMDM (Agentia Nationala a Medicamentului si a Dispozitivelor Medicale)

lezra 2,5 mg

sindan-pharma s.r.l. - romania - letrozolum - compr. film. - 2,5mg - antagonisti hormonali si substante inrudite inhibitori enzimatici